An initiative for living evidence synthesis in clinical psychedelic research

Abstract

Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision-making. This Comment explores the current landscape of clinical psychedelic research, highlighting the need for a systematic approach to evidence synthesis.